Background. This study was aimed to evaluate achievements of medical health care services in Lithuania by analysing time trends in avoidable cancer mortality of the whole Lithuanian population from 1992 through 2008.
INTRODUCTION
Avoidable mortality is defined as untimely death that may have been prevented by the timely provision of appropriate medical intervention (1) , and it is frequently used as a statistical indicator of the achievements of medical health care services in order to assess the improvement of health level independently of other socioeconomic factors (2) .
In the middle of 1990, Lithuania declared independence. Since then, Lithuania has experienced many changes that have, directly or indirectly, affected the health care system. Earlier studies have examined the scale of avoidable mortality in Lithuania for the period 1970-1990 (3) ; later, changes in avoidable cancer mortality in 1991-1999 were compared with the previous period (4) . Avoidable mortality in Lithuania is reported to be higher than in Western Europe (5) .
Cancer in Lithuania, like in other European countries, is the second most frequent cause of death. The analysis of mortality trends is an important tool of monitoring cancer control and evaluating the outcomes of modifications in population lifestyle, environmental risks as well as the effectiveness of health care. The analysis of cancer mortality time trends and patterns in a given population can be helpful in assessing achievements, failures and future needs in cancer control programs (5) .
The concept of 'avoidable' mortality has changed over time, and some problems such as the ambiguity of the definition and some arbitrariness in disease selection still remain unresolved (6, 7) . In this study, selection of the list of avoidable cancer deaths is based on the classification proposed by Simonato et al. (8) .
This study aims to evaluate the achievement of medical health care services in Lithuania by analysing the time trends in avoidable cancer mortality of the whole Lithuanian population from 1992 to 2008, based on cancer mortality data collected by the Lithuanian Cancer Registry.
MATERIALS AND METHODS
A list of avoidable deaths from cancer was compiled following the categorization of the avoidable causes of death, proposed by Simonato et al., where the avoidable causes of death in the list were categorized into those amenable to primary prevention (group 1), those amenable to early detection and treatment (group 2), and those amenable to improved treatment and medical care (group 3). These groups were defined as:
1. Causes avoidable through primary prevention, i. e. by reducing the incidence of the disease. This category includes causes whose aetiology is in part attributable to lifestyle factors (such as alcohol and / or tobacco consumption) and / or to occupational risk factors. It also includes deaths from injury and poisoning, which are influenced in part by legal and societal measures such as traffic safety and crime reduction policies.
2. Causes amenable to secondary prevention through early detection and treatment. This group includes the causes of death for which screening modalities have been established, such as cancer of breast and cervix, as well as causes in which death is avoidable through early detection combined with adequate treatment, such as skin cancer.
3. Causes amenable to improved treatment and medical care. This group includes infectious diseases in which deaths are 'avoidable' largely through antibiotic treatment and immunization, as well as the causes that require medical and / or surgical intervention, such as hypertension, appendicitis, in which deaths are related to "complex interactions within the health care system, such as accurate diagnosis, transport to hospital, adequate medical and surgical care".
Data of the Lithuanian Cancer Registry for the years 1992-2008 were used to analyse avoidable cancer mortality trends. Cancer mortality statistics are based on the underlying causes of death as reported in the medical certificate of death by the certifying physician. Causes of death were co ded according to the International Classification of Diseases, 9th revision, for the period 1992-1997, and according to the International Classification of Diseases, 10th revision, for the period 1997-2008. The corresponding population data by age, sex and year were available from Statistics Lithuania. The age of the study subjects was limited to a range between 5 and 75 years.
Mortality rates for all cancer and selected cancer sites were analysed. Age-standardised rates were calculated for both sexes. Standardization was performed using the direct method (European standard population). The estimated annual percentage change (EAPC) was computed for trends by means of generalized linear models. Joinpoint software version 3.4.3 was used for the analysis (National Cancer Institute: Joinpoint Regression Program Version 2.6. Available from: URL:http://srab.cancer.gov/joinpoint/download.html).
RESULTS
The mortality rate has been decreasing continuously over time in both sexes. The degree of reduction in total cancer mortality was slightly higher in females than in males. There were no joinpoints found in male or female data; standardised rates steadily go down on average by 0.83% (95% CI from -1.14 to -0.52) per year for males and 1.03% (95% CI from -1.40 to -0.66) for females. Table 3 shows the time trend of avoidable cancer mortality rates according to each category of medical intervention effectiveness for preventing death from cancer. Mortality avoidable by medical intervention has been continuously decreasing since 1992 in both sexes by more than 2% per year, while mortality avoidable by primary prevention decreased only in males. Cancer mortality avoidable by secondary prevention was decreasing in females and increasing in males.
Results of the joinpoint analysis by sex and cancer site are reported in Table 3 . There are differences in avoidable mortality cancer groups by individual cancer sites. In cancer mortality avoidable by primary prevention, mortality from cancer of the upper airways and digestive tract was stable in both sexes, and lung cancer mortality was sta- ble only in females. Mortality from trachea, bronchus and lung cancer was decreasing on average by 1.98% in males.
Mortality from bladder cancer also shows diminution with EAPC of -2.62 (males) and -3.02 (females). Mortality from melanoma and other skin cancers shows an uprising trend in males (EAPC 2.85%) and a stable trend in females. Mortality from breast cancer, the major cause of death for the female population, shows a decreasing trend by 1.13% per year over the study period. Female mortality rates from cervical cancer were stable. Mortality rates from the cancer of uterus are not in line with cervix cancer and are steadily decreasing over the whole period. The average change in mortality from uterus cancer is -2.26%.
Being overall low, mortality rates of cancer avoidable through improved treatment and medical care are decreasing in Lithuania in all cancer sites studied. Mortality rates from testicular cancer are decreasing, and for the study period the EAPC is -2.53 with 95% CI from -4.56 to -0.47. Mortality rates from Hodgkin's disease are going down for both sexes: EAPC for males is -6.90 and for females -5.80. Leukaemia mortality rates also show a consistent downtrend which is 2.00% per year for the male and -1.58% for the female population.
DISCUSSION
In general, avoidable mortality is declining in European countries (8) . In Sweden, avoidable mortality between 1974 and 1985 declined in male and female populations (9) . A study in Belgium also showed a decrease in avoidable mortality between 1974 and 1994 (10). All European countries, except Hungary, showed a 2.4% annual reduction in avoidable mortality between 1980 and 1997 (11) . Avoidable mortality in Lithuania in 1991-1999 increased as compared with 1970-1990 (4) . Avoidable cancer mortality is usually studied in broad categories of avoidable deaths. These broad categories obscure the potentially contradictory trend in specific groups of causes. It is thus necessary to consider in detail some components in each category. In previous studies of avoidable mortality in Lithuania, the increasing lung and cervical cancer mortality was reported for the period 1971-1990 (4) ; an increase of these cancer sites was also found for the period 1991-1999 (4) .
During the period 1992-2008, cancer mortality in Lithuania has been decreasing. This reduction was greatly attributable to the reduction of avoidable mortality, an indicator reflecting the quality of medical health care ser vice. There were noticeable differences between males and females in the patterns and trends of cancer mortality according to the category of medical intervention proven effective for disease prevention. These figures, while having some explanatory power, do mask considerable fluctuations of cancer mortality by site. Cancer mortality avoidable by medical intervention in Lithuania has been decreasing since 1992 in both sexes, although mortality rates in this group of avoidable cancer are low. In the category of mortality avoidable by secondary prevention, mortality rates were higher in females than in males, and a reduction in mortality over the study period was observed only in females. This finding suggests that there might be an inequality between sexes in terms of the usage of preventive medical services in Lithuania. Mortality associated with cervical cancer, which is known to be preventable by secondary prevention, was not decreasing in Lithuania. Also, the delayed introduction of secondary prevention and low participation rates in cervical cancer screening programs were likely the main reasons for the stable trend. Cancer mortality avoidable by primary prevention was decreasing in male and stable in female populations. This observation is valid for lung cancer mortality, which has been decreasing in males. Mortality rates in females were low; therefore, the decrease was not significant. This finding could have been the result of decreasing smoking rates or other changes in smoking behaviour.
To our knowledge, our study is the first to examine the contribution of medical health care services to the improvement of the population health level, using avoidable cancer mortality as an indicator of the quality of medical services in Lithuania. Any division of the indicators of avoidable mortality, used in this study, is to some extent artificial. Despite this limitation, the findings of our study are valuable because they prove that the quality medical health care service significantly contributes to the prevention of untimely and unavoidable deaths. Furthermore, findings of our study can be used to facilitate further improvements in the population health level.
CONCLUSIONS
In Lithuania, a remarkable reduction in avoidable cancer mortality over the past decade has been noted. However, the rate of reduction was slower for mortality avoidable by primary or secondary prevention methods than for that preventable by direct medical care, indicating that there is a need to put more effort towards primary and secondary prevention.
ACkNOwLEDGEMENT
Financial support from the Research Council of Lithuania (grant No. SIN-14/2010) is gratefully acknowledged.
